HS

HS HYOSUNG Corporation

A holding company for advanced materials, AI/data solutions, mobility, and global logistics.

487570 | KO

Overview

Corporate Details

ISIN(s):
KR7487570004
LEI:
Country:
South Korea
Address:
서울특별시 마포구 마포대로 119 (공덕동), 서울특별시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

HS HYOSUNG Corporation is a holding company operating across four core business sectors: Advanced Materials, AI/Data Solutions, Mobility, and Supply Chain Management (SCM). The Advanced Materials division is a leading producer of high-tech materials, including PET tire cords and carbon fiber, through subsidiaries like HS HYOSUNG ADVANCED MATERIALS. The AI/Data Solutions segment, led by HS HYOSUNG INFORMATION SYSTEMS, provides integrated cloud infrastructure, AI platforms, and storage technology. Its Mobility division offers premium automotive and mobility solutions, while the SCM arm delivers optimized global logistics services. The company's mission is to create value and contribute to a better future through continuous technological development and innovation.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-19 00:00
Related Party Transaction
[기재정정]금전대여결정(자회사의 주요경영사항)
Korean 22.1 KB
2025-09-17 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 117.1 KB
2025-09-17 00:00
Major Shareholding Notification
최대주주등소유주식변동신고서
Korean 55.3 KB
2025-09-12 00:00
Capital/Financing Update
타인에대한채무보증결정(자회사의 주요경영사항)
Korean 22.6 KB
2025-08-29 00:00
Related Party Transaction
대규모기업집단현황공시[분기별공시(개별회사용)]
Korean 15.3 KB
2025-08-18 00:00
Related Party Transaction
타인에대한채무보증결정(자회사의 주요경영사항)
Korean 22.8 KB
2025-08-14 00:00
Regulatory News Service
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
Korean 11.2 KB
2025-08-14 00:00
Related Party Transaction
동일인등출자계열회사와의상품ㆍ용역거래변경
Korean 19.5 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 2.6 MB
2025-07-31 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 15.8 KB
2025-07-04 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 108.1 KB
2025-07-04 00:00
M&A Activity
[기재정정]영업양도결정(종속회사의주요경영사항)
Korean 15.9 KB
2025-06-04 00:00
Capital/Financing Update
타인에대한채무보증결정(자회사의 주요경영사항)
Korean 22.3 KB
2025-06-02 00:00
Major Shareholding Notification
대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
Korean 184.2 KB
2025-05-30 00:00
M&A Activity
영업양도결정(종속회사의주요경영사항)
Korean 11.7 KB

Automate Your Workflow. Get a real-time feed of all HS HYOSUNG Corporation filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HS HYOSUNG Corporation

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HS HYOSUNG Corporation via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Advancing high-grade copper and precious metal projects from discovery to production.
Canada
COR
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden
CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland
CTX
Cardiff Oncology, Inc. Logo
Clinical-stage biotech developing a PLK1 inhibitor to treat resistant cancers.
United States of America
CRDF
Cardio Diagnostics Holdings, Inc. Logo
AI-powered epigenetic and genetic tests for early detection of heart disease risk.
United States of America
CDIO
Cardiol Therapeutics Inc. Logo
Develops oral cannabidiol therapies for inflammatory and fibrotic heart diseases.
United States of America
CRDL
CareDx, Inc. Logo
Precision diagnostics and surveillance solutions for the organ transplant journey.
United States of America
CDNA
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan
6070
Caris Life Sciences, Inc. Logo
Pioneering precision cancer care via AI-powered molecular profiling and diagnostics.
United States of America
CAI
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan
4572

Talk to a Data Expert

Have a question? We'll get back to you promptly.